Youngchul Song

10.4k citations
18 papers · 5.5k indexed · 1 hit paper · h-index 13
Topics
PI3K/AKT/mTOR signaling in cancer (7 papers)HER2/EGFR in Cancer Research (4 papers)Lung Cancer Treatments and Mutations (4 papers)

In The Last Decade

Youngchul Song

17 papers receiving 5.4k citations

Hit Papers

MET Amplification Leads to Gefitinib Resistance in Lung C...2007202620132019200710002.0k3.0k

Peers

Youngchul Song
Comparison fields: 5 of 98
  • Oncology 3.0k
  • Molecular Biology 3.0k
  • Pulmonary and Respiratory Medicine 2.7k
  • Cancer Research 908
  • Hepatology 608
Replace Kreshnik Zejnullahu with:
Kreshnik Zejnullahu United States
Todd M. Bauer United States
Colin S. Cooper United Kingdom
Francesca Molinari Switzerland
Silvio Veronese Italy
Gaia Schiavon United Kingdom
Samuel J. Klempner United States
Milo Frattini Italy
Takayuki Kosaka Japan
Andrea Bertotti Italy
Youngchul Song relative to Kreshnik Zejnullahu United States Kreshnik Zejnullahu's profile →
Citations per field
00.5×1.5×
Kreshnik Zejnullahu · 1×
Citations per year

Countries citing papers authored by Youngchul Song

Since Specialization
Citations

This map shows the geographic impact of Youngchul Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youngchul Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youngchul Song more than expected).

Fields of papers citing papers by Youngchul Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youngchul Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youngchul Song. The network helps show where Youngchul Song may publish in the future.

Co-authorship network of co-authors of Youngchul Song

This figure shows the co-authorship network connecting the top 25 collaborators of Youngchul Song. A scholar is included among the top collaborators of Youngchul Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youngchul Song. Youngchul Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 0
2 26
3 19
4 123
5 173
6 174
7 1
8 51
9 1
10 285
11 87
12 118
13 9
14 153
15 7
16 215
17 455
18
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signalingbreakdown →
3570

About Youngchul Song

Youngchul Song is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine, having authored 18 papers that have together received 5.5k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (7 papers), HER2/EGFR in Cancer Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Oncology (3.0k citations), Pulmonary and Respiratory Medicine (2.7k citations) and Hepatology (608 citations). Youngchul Song has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Jeffrey A. Engelman, Lewis C. Cantley, Pasi A. Jänne, Xiao‐Jun Zhao, James G. Christensen, Charles Lee, Neal I. Lindeman, Kreshnik Zejnullahu, Tony Mok and Takayuki Kosaka. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026